Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Zelegent logo — Sleep Better. Live Better. Reduce the severity of snoring a...

Zelegent

Sleep Better. Live Better. Reduce the severity of snoring and the associated negative health effects.

Founded 2015 United States Newport Beach, United States 3 employees Venture round Total: $11.15M Health Care, Medical Devices

General Information

Company Name Zelegent
Founded Year 2015
Location United States Newport Beach, United States
Employees 3
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Zelegent. To contact Zelegent, visit zelegent.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Zelegent compare?

A PDF of Zelegent and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Zelegent soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Zelegent

Zelegent Inc. is a medical technology company founded in 2015, headquartered in United States, with the slogan "Sleep Better. Live Better." Zelegent focuses on reducing the severity of snoring, a common cause of short-term and long-term health issues. The company's flagship product is the Elevo® Snoring Intervention Set, which enables physicians to perform Elevoplasty® - a minimally invasive, physician’s office-based procedure designed to treat patients with mild to moderate snoring. The S.I.LE.N.C.E. Clinical Study, submitted to the FDA to achieve FDA Clearance, demonstrated that 3 out of 4 patients experienced a reduction in snoring at 30 days post-procedure and significant improvement in sleep quality and daytime alertness. This study is available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042659/. With a $8.65M Venture Round investment received on 09 October 2020, Zelegent is making strides in the Health Care industry, addressing an issue that affects approximately 45% of people who snore at least sometimes and 25% who snore regularly at volumes high enough to disturb sleeping partners. The negative impact of snoring on health, including the risk of Obstructive Sleep Apnea, heart conditions, and other serious health issues, highlights the significance of Zelegent's mission. Zelegent's innovation not only targets the health of individuals who snore but also aims to improve the sleep quality and well-being of their partners. With a focus on addressing both short-term and long-term health effects, Zelegent has the potential to make a substantial difference in the lives of many.

Business keywords: Sleep Technology, Snoring Treatment, Minimally Invasive Procedure, Health Innovation, Sleep Quality Improvement, Sleep Disorders, ENT Health, Obstructive Sleep Apnea, Sleep Health, Clinical Studies, Sleep Medicine, Patient Wellness, Medical Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $8.65M -
09 Oct 2020
Seed Round $2.50M -
19 Nov 2015
Non Equity Assistance Undisclosed 1
EvoNexus
EvoNexus
08 May 2015

Zelegent Alternatives & Competitors

View All Alternatives
Zelegent vs
Inspire Medical Systems
Inspire Medical Systems United States

We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea.

Post-IPO Equity
1195 employees
Biotechnology, Health Care
Zelegent vs
XII Medical
XII Medical

Minimally Invasive Technology for Obstructive Sleep Apnea

Series A
34 employees
Health Care, Health and Wellness
Zelegent vs
ZOLL Itamar
ZOLL Itamar United States

Home Sleep Apnea Test and Digital Health Company.

Post-IPO Secondary
310 employees
Health Care, Medical Devices
Compare Zelegent vs ZOLL Itamar
View all alternatives

FAQ About Zelegent

Sleep Better. Live Better. Reduce the severity of snoring and the associated negative health effects.
Zelegent was founded in 2015.
Zelegent is headquartered in Newport Beach, United States.
Zelegent operates in Health Care and Medical Devices. Its work centres on Sleep Technology, Snoring Treatment, Minimally Invasive Procedure and Health Innovation.
Zelegent has approximately 3 employees.
Zelegent has completed 3 funding rounds, raising a total of $11.15M. The latest funding stage is Venture round.
Top alternatives and competitors to Zelegent include Inspire Medical Systems, XII Medical, ZOLL Itamar, LinguaFlex LLC, Primasun. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zelegent and Inspire Medical Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zelegent, https://bouncewatch.com/company/zelegent, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout